We are live on ! Find out more
SG

StepStone Group Portfolio holdings

AUM $207M
1-Year Est. Return 12.33%
This Fund
S&P 500
This Quarter Est. Return
+3.9%
1 Year Est. Return
-12.33%
3 Year Est. Return
+92.06%
5 Year Est. Return
+17.44%
10 Year Est. Return
+217.33%
AUM
$541M
AUM Growth
+$2.65M
Cap. Flow
+$2.21M
Cap. Flow %
0.41%
Top 10 Hldgs %
96.44%
Holding
26
New
5
Increased
6
Reduced
2
Closed
2

Top Sells

Rank Stock Value
1
PCOR icon
Procore
PCOR
+$461K
2
TWAV
TaoWeave Inc
TWAV
+$404K
3
RKLB icon
Rocket Lab Corp
RKLB
+$327K
4
NEUE
NeueHealth
NEUE
+$40

Sector Composition

Rank Sector Weight
1 Financials 49.66%
2 Technology 24.28%
3 Industrials 13.97%
4 Healthcare 7.88%
5 Communication Services 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNB
1
DELISTED
Dun & Bradstreet
DNB
$255M 47.16%
22,042,226
WKME
2
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$99.5M 18.4%
10,366,855
RKLB icon
3
Rocket Lab Corp
RKLB
$42.3B
$73.2M 13.54%
12,202,096
-71,318
-0.6% -$327K
PATH icon
4
UiPath
PATH
$6.3B
$29.9M 5.53%
1,805,596
+19,069
+1% +$306K
RBLX icon
5
Roblox
RBLX
$37B
$18.9M 3.5%
469,052
+2,386
+0.5% +$95.8K
HLVX
6
DELISTED
HilleVax
HLVX
$11.6M 2.15%
676,569
TRDA icon
7
Entrada Therapeutics
TRDA
$267M
$11.5M 2.13%
761,277
ML
8
DELISTED
MoneyLion Inc.
ML
$9.36M 1.73%
779,050
+1
+0% +$12
NEUE
9
DELISTED
NeueHealth
NEUE
$6.42M 1.19%
525,249
-3
-0% -$40
PHAT icon
10
Phathom Pharmaceuticals
PHAT
$873M
$6.04M 1.12%
422,085
NGM
11
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.07M 0.75%
1,573,357
ROVR
12
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$3.16M 0.58%
643,394
DOMA
13
DELISTED
Doma Holdings, Inc.
DOMA
$2.94M 0.54%
595,179
TNYA icon
14
Tenaya Therapeutics
TNYA
$177M
$2.71M 0.5%
462,163
VCSA
15
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$2M 0.37%
147,261
AFRM icon
16
Affirm
AFRM
$25.5B
$1.25M 0.23%
+81,445
New +$1.08M
FRSH icon
17
Freshworks
FRSH
$3.01B
$803K 0.15%
45,674
+30,282
+197% +$455K
CFLT
18
DELISTED
Confluent
CFLT
$691K 0.13%
19,558
+17,110
+699% +$479K
GROV icon
19
Grove Collaborative
GROV
$45.4M
$673K 0.12%
380,383
+3,038
+0.8% +$6.68K
HCP
20
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$387K 0.07%
+14,767
New +$433K
AGTI
21
DELISTED
Agiliti Inc
AGTI
$332K 0.06%
+20,101
New +$337K
MIRM icon
22
Mirum Pharmaceuticals
MIRM
$7.25B
$108K 0.02%
+4,179
New +$111K
PGNY icon
23
Progyny
PGNY
$2.5B
$102K 0.02%
+2,597
New +$93.7K
AMRS
24
DELISTED
Amyris Inc.
AMRS
$2.9K ﹤0.01%
2,816
TWAV
25
TaoWeave Inc
TWAV
$4.04M
-6,155
Closed -$404K

Similar funds

StepStone Group's Q2 2023 Portfolio in Review

As of Q2 2023, StepStone Group held 26 positions worth $541M, up 0.49% from $538M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

StepStone Group's Q2 2023 filing shows 5 new, 6 increased, 2 reduced and 2 closed positions. Its largest new stake was Affirm: 81,445 shares worth $1.25M. The largest sale was Procore, an estimated $461K.

By sector, the portfolio is most concentrated in Financials at 50% of assets, down from 51% a quarter earlier, followed by Technology and Industrials.

  • StepStone Group's largest Q2 2023 buy was Affirm: 81,445 shares worth $1.25M.
  • StepStone Group added most to Confluent in Q2 2023, an estimated $479K increase.
  • StepStone Group's biggest Q2 2023 reduction was Rocket Lab Corp, cutting an estimated $327K.
  • StepStone Group fully exited Procore in Q2 2023, selling an estimated $461K.
  • StepStone Group's ten largest holdings make up 96% of its $541M portfolio in Q2 2023.
  • StepStone Group opened 5 new positions and closed 2 in Q2 2023.
  • StepStone Group's portfolio value rose 0.49% quarter-over-quarter to $541M.

Based on StepStone Group's 13F filing for Q2 2023, filed 14 Aug 2023.